logo

Calliditas Therapeutics Ab (Publ) (CALT)



Trade CALT now with
  Date
  Headline
1/18/2021 2:40:48 AM Genkyotex Announces Positive Phase 1 Data In In High-dose Setanaxib Trial
11/8/2020 11:52:28 PM Calliditas Announces Positive Topline Results From Pivotal Phase 3 NefIgArd Trial
9/8/2020 2:47:47 AM Calliditas Therapeutics Says First Patient In China Enrolled In Clinical Phase 3 Study NefIgArd With Nefecon